Harvard Bioscience (HBIO) Debt/Assets Ratio: History & Chart

Harvard Bioscience, Inc.(HBIO)

Medical - Instruments & Supplies · Holliston, MA

$8.68+0.18 (+2.12%)

Delayed quote: Oct 6, 2026, 10:30 AM EDT

About Harvard Bioscience, Inc.

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through websites and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic laboratories. It primarily sells its products under the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS, Warner, DSI, Panlab, Hugo Sachs, and Buxco brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.

Holliston, MA

328 employees

www.harvardbioscience.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: John D. Duke

View full financials

HBIO Debt to Assets Ratio Metrics

DEBT TO ASSETS RATIO

57.95%

DEBT TO ASSETS RATIO AVG TTM

55.76%

DEBT TO ASSETS RATIO AVG 3Y

43.47%

DEBT TO ASSETS RATIO AVG 5Y

40.62%

DEBT TO ASSETS RATIO AVG 10Y

35.65%

DEBT TO ASSETS RATIO AVG 15Y

28.04%

DEBT TO ASSETS RATIO AVG 20Y

22.63%

CURRENT VS TTM AVG

+3.93%

CURRENT VS 3Y AVG

+33.30%

CURRENT VS 5Y AVG

+42.67%

CURRENT VS 10Y AVG

+62.55%

CURRENT VS 15Y AVG

+106.68%

CURRENT VS 20Y AVG

+156.06%

SECTOR MEDIAN · HEALTHCARE

0.10%

median of 595 covered companies

CURRENT VS SECTOR MEDIAN

+57847.72%

vs the sector median at left

NAME	MARKET CAP	DEBT TO ASSETS RATIO	TTM	3Y	5Y
Harvard Bioscience, Inc. (HBIO)	$39.15M	57.95%	55.76%	43.47%	40.62%
Nephros, Inc. (NEPH)vs ›	$38.76M	0.06%	N/A	N/A	N/A
Incannex Healthcare Limited (IXHL)vs ›	$38.82M	0.00%	N/A	N/A	N/A
Edesa Biotech, Inc. (EDSA)vs ›	$36.92M	0.00%	N/A	N/A	N/A
Metagenomi, Inc. Common Stock (MGX)vs ›	$40.28M	0.22%	N/A	N/A	N/A
Elicio Therapeutics, Inc. (ELTX)vs ›	$36.61M	0.45%	N/A	N/A	N/A
DocGo Inc. (DCGO)vs ›	$36.32M	0.14%	N/A	N/A	N/A
Accuray Incorporated (ARAY)vs ›	$36.17M	0.41%	N/A	N/A	N/A
BriaCell Therapeutics Corp. (BCTX)vs ›	$35.58M	0.00%	N/A	N/A	N/A
CVRx, Inc. (CVRX)vs ›	$41.56M	0.64%	N/A	N/A	N/A

NAME

MARKET CAP

DEBT TO ASSETS RATIO

TTM

Harvard Bioscience, Inc. (HBIO)

$39.15M

57.95%

55.76%

43.47%

40.62%

Nephros, Inc. (NEPH)vs ›

$38.76M

0.06%

N/A

Incannex Healthcare Limited (IXHL)vs ›

$38.82M

0.00%

N/A

Edesa Biotech, Inc. (EDSA)vs ›

$36.92M

0.00%

N/A

Metagenomi, Inc. Common Stock (MGX)vs ›

$40.28M

0.22%

N/A

Elicio Therapeutics, Inc. (ELTX)vs ›

$36.61M

0.45%

N/A

DocGo Inc. (DCGO)vs ›

$36.32M

0.14%

N/A

Accuray Incorporated (ARAY)vs ›

$36.17M

0.41%

N/A

BriaCell Therapeutics Corp. (BCTX)vs ›

$35.58M

0.00%

N/A

CVRx, Inc. (CVRX)vs ›

$41.56M

0.64%

N/A

Debt to Assets Ratio FAQ

What is the debt to assets ratio for Harvard Bioscience, Inc. (HBIO)?

The debt to assets ratio for HBIO stock is 57.95%.

Is Harvard Bioscience, Inc.'s debt to assets ratio high or low?

The debt to assets ratio of 57.95% is 43% above its 5-year average of 40.62%, near the high end of its 5-year range (31.06%–57.95%).

What is the TTM average debt to assets ratio for Harvard Bioscience, Inc. (HBIO)?

The TTM average debt to assets ratio for HBIO stock is 55.76%.

What is the 3Y average debt to assets ratio for Harvard Bioscience, Inc. (HBIO)?

The 3Y average debt to assets ratio for HBIO stock is 43.47%.

What is the 5Y average debt to assets ratio for Harvard Bioscience, Inc. (HBIO)?

The 5Y average debt to assets ratio for HBIO stock is 40.62%.

What is the 10Y average debt to assets ratio for Harvard Bioscience, Inc. (HBIO)?

The 10Y average debt to assets ratio for HBIO stock is 35.65%.

What is the 15Y average debt to assets ratio for Harvard Bioscience, Inc. (HBIO)?

The 15Y average debt to assets ratio for HBIO stock is 28.04%.

What is the 20Y average debt to assets ratio for Harvard Bioscience, Inc. (HBIO)?

The 20Y average debt to assets ratio for HBIO stock is 22.63%.

DATE	DEBT TO ASSETS RATIO
2026-06-30	57.95%
2026-03-31	56.61%
2025-12-31	55.30%
2025-09-30	54.86%
2025-06-30	54.08%
2025-03-31	55.90%
2024-12-31	35.13%
2024-09-30	34.82%
2024-06-30	32.15%
2024-03-31	31.06%
2023-12-31	31.14%
2023-09-30	32.41%
2023-06-30	33.73%
2023-03-31	35.12%
2022-12-31	37.31%
2022-09-30	38.71%
2022-06-30	36.32%
2022-03-31	36.24%
2021-12-31	35.09%
2021-09-30	35.13%
2021-06-30	33.88%
2021-03-31	34.90%
2020-12-31	36.86%
2020-09-30	35.66%
2020-06-30	35.75%
2020-03-31	37.92%
2019-12-31	39.10%
2019-09-30	33.37%
2019-06-30	39.59%
2019-03-31	39.51%
2018-12-31	36.17%
2018-09-30	36.99%
2018-06-30	37.23%
2018-03-31	36.84%
2017-12-31	10.74%
2017-09-30	11.24%
2017-06-30	12.12%
2017-03-31	12.71%
2016-12-31	12.76%
2016-09-30	13.41%
2016-06-30	14.17%
2016-03-31	14.55%
2015-12-31	15.72%
2015-09-30	15.09%
2015-06-30	14.90%
2015-03-31	16.33%
2014-12-31	15.78%
2014-09-30	17.04%
2014-06-30	16.16%
2014-03-31	17.37%
2013-12-31	18.27%
2013-09-30	15.84%
2013-06-30	16.60%
2013-03-31	11.08%
2012-12-31	9.70%
2012-09-30	11.72%
2012-06-30	12.43%
2012-03-31	12.77%
2011-12-31	12.87%
2011-09-30	12.84%
2011-06-30	13.26%
2011-03-31	13.42%
2010-12-31	14.43%
2010-09-30	14.97%
2010-06-30	10.84%
2010-03-31	11.15%
2009-12-31	12.42%
2009-09-30	8.49%
2009-06-30	0.65%
2009-03-31	1.21%
2008-12-31	1.75%
2008-09-30	2.55%
2008-06-30	2.25%
2008-03-31	2.45%
2007-12-31	7.84%
2007-09-30	2.91%
2007-06-30	0.22%
2007-03-31	1.64%
2006-12-31	3.22%
2006-09-30	3.31%
2006-06-30	7.03%
2006-03-31	9.27%
2005-12-31	9.26%
2005-09-30	13.60%
2005-06-30	14.17%
2005-03-31	11.22%
2004-12-31	11.82%
2004-09-30	13.19%
2004-06-30	13.56%
2004-03-31	14.50%
2003-12-31	10.27%
2003-09-30	0.36%
2003-06-30	5.67%
2003-03-31	6.09%
2002-12-31	1.02%
2002-09-30	1.28%

DATE

DEBT TO ASSETS RATIO

2026-06-30

57.95%

2026-03-31

56.61%

2025-12-31

55.30%

2025-09-30

54.86%

2025-06-30

54.08%

2025-03-31

55.90%

2024-12-31

35.13%

2024-09-30

34.82%

2024-06-30

32.15%

2024-03-31

31.06%

2023-12-31

31.14%

2023-09-30

32.41%

2023-06-30

33.73%

2023-03-31

35.12%

2022-12-31

37.31%

2022-09-30

38.71%

2022-06-30

36.32%

2022-03-31

36.24%

2021-12-31

35.09%

2021-09-30

35.13%

2021-06-30

33.88%

2021-03-31

34.90%

2020-12-31

36.86%

2020-09-30

35.66%

2020-06-30

35.75%

2020-03-31

37.92%

2019-12-31

39.10%

2019-09-30

33.37%

2019-06-30

39.59%

2019-03-31

39.51%

2018-12-31

36.17%

2018-09-30

36.99%

2018-06-30

37.23%

2018-03-31

36.84%

2017-12-31

10.74%

2017-09-30

11.24%

2017-06-30

12.12%

2017-03-31

12.71%

2016-12-31

12.76%

2016-09-30

13.41%

2016-06-30

14.17%

2016-03-31

14.55%

2015-12-31

15.72%

2015-09-30

15.09%

2015-06-30

14.90%

2015-03-31

16.33%

2014-12-31

15.78%

2014-09-30

17.04%

2014-06-30

16.16%

2014-03-31

17.37%

2013-12-31

18.27%

2013-09-30

15.84%

2013-06-30

16.60%

2013-03-31

11.08%

2012-12-31

9.70%

2012-09-30

11.72%

2012-06-30

12.43%

2012-03-31

12.77%

2011-12-31

12.87%

2011-09-30

12.84%

2011-06-30

13.26%

2011-03-31

13.42%

2010-12-31

14.43%

2010-09-30

14.97%

2010-06-30

10.84%

2010-03-31

11.15%

2009-12-31

12.42%

2009-09-30

8.49%

2009-06-30

0.65%

2009-03-31

1.21%

2008-12-31

1.75%

2008-09-30

2.55%

2008-06-30

2.25%

2008-03-31

2.45%

2007-12-31

7.84%

2007-09-30

2.91%

2007-06-30

0.22%

2007-03-31

1.64%

2006-12-31

3.22%

2006-09-30

3.31%

2006-06-30

7.03%

2006-03-31

9.27%

2005-12-31

9.26%

2005-09-30

13.60%

2005-06-30

14.17%

2005-03-31

11.22%

2004-12-31

11.82%

2004-09-30

13.19%

2004-06-30

13.56%

2004-03-31

14.50%

2003-12-31

10.27%

2003-09-30

0.36%

2003-06-30

5.67%

2003-03-31

6.09%

2002-12-31

1.02%

2002-09-30

1.28%

Debt to Assets Ratio: 57.95%

HBIO Debt to Assets Ratio

HBIO Average Debt to Assets Ratio Chart

HBIO Current vs Average Debt to Assets Ratio Chart

HBIO Debt to Assets Ratio Metrics

HBIO Competitors' Debt to Assets Ratio

Leverage Ratios Comparison

Debt to Assets Ratio Formula & Definition

Debt to Assets Ratio FAQ

HBIO Debt to Assets Ratio History

Related Metrics